Paneled capsule shells for release of pharmaceutical compositions
First Claim
1. Capsule shell for connection to a linker in multipart dosage form, the capsule shell comprising:
- a generally cylindrical shell member having an interior, a longitudinal axis, an outer surface, a closed end, and an open end, the open end being configured to connect to the linker, and the closed end being generally rounded; and
one or more panels adjacent the closed end and circumferentially spaced apart about the axis, each of the panels being integral with the shell member and configured to have a thickness thinner than a thickness of an adjacent shell member portion.
5 Assignments
0 Petitions
Accused Products
Abstract
Capsule shells for use in multi-part dosage forms have generally cylindrical shell members with a snap fit component on an interior surface adjacent an open end, for connection to a linker part of the dosage form. The shell member also has a plurality of spaced apart integrally formed thin (relative to circumferentially adjacent shell member portions) panels located adjacent a closed shell member end, for preferential dissolution and release of pharmaceutical compositions from the shell member interior. The ratio of the thickness of the panels to the thickness of the shell member ranges from about 0.2 to about 0.6. The panels can be integrally formed together with the shell member as reliefs or depressions on the inner surface of the shell member by injection molding, and panel thicknesses as thin as about 0.1 mm can be achieved,
-
Citations
32 Claims
-
1. Capsule shell for connection to a linker in multipart dosage form, the capsule shell comprising:
-
a generally cylindrical shell member having an interior, a longitudinal axis, an outer surface, a closed end, and an open end, the open end being configured to connect to the linker, and the closed end being generally rounded; and one or more panels adjacent the closed end and circumferentially spaced apart about the axis, each of the panels being integral with the shell member and configured to have a thickness thinner than a thickness of an adjacent shell member portion. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
-
-
11. The capsule shell as in claim 11, wherein the material is selected from the group consisting of hydroxypropyl cellulose, hydroxypropyl methylcellulose acetate succinate, polyvinyl alcohol, hydroxypropyl methyl cellulose, and acrylic or methacrylic acid-based polymers.
-
26. An injection molded capsule shell for use as part of a dosage form, the capsule shell comprising:
-
a generally cylindrical shell member having an interior, a longitudinal axis, an inner surface, an outer surface, a closed end, and an open end, the open end being configured to connect to another part of the dosage form, and the closed end being generally rounded; and one or more panels positioned within the rounded closed end and circumferentially spaced apart about the axis, the panels comprising reliefs or depressions in the inner surface, the panels being formed by injection molding with the shell member and configured to have a thickness thinner than a thickness of a circumferentially adjacent shell member portion. - View Dependent Claims (27, 28, 29, 30, 31, 32)
-
Specification